Luke Whiley
Murdoch University, WA, Australia
- This delegate is presenting an abstract at this event.
Dr Whiley is a Dementia Australia/Royce Simmons Foundation Mid-Career Research Fellow and a Senior Lecturer in Phenomics, Healthy Ageing and Dementia at the Australian National Phenome Centre (ANPC) at Murdoch University. Dr Whiley has extensive experience of bioanalytical chemistry and bioinformatics in phenomics workflows, encompassing PhD, industry, and post-doctoral research, and currently is a theme leader at the Australian National Phenome Centre where he focuses on the development and application of phenomics platforms to investigate the systemic phenotypes that define health and disease throughout ageing.
Dr Whiley completed a PhD in Translational Medicine (King’s College London, UK, 2013), developing mass spectrometry lipidomic assays, with subsequent application to clinical sample sets in ageing and dementia. Post-PhD, CI Whiley developed extensive bioanalytical chemistry experience with positions within accredited industrial laboratories (UK anti-doping laboratory, UK), resulting in expertise in data quality and analytical rigour. Dr. Whiley completed a post-doctoral research associate at the UK National Phenome Centre and Dementia Research Institute, Imperial College London (UK), continuing development of cutting-edge metabolic phenotyping platforms and bioinformatic modelling in clinical and epidemiology studies to investigate metabolic phenotypes associated with dementia and disease risk.
Presentations this author is a contributor to:
Phenotyping the host-gut microbe co-metabolome to investigate the gut-brain axis in health and disease (#216)
9:45 AM
Luke Whiley
Concurrent Session - Human Microbiomes
The metabolic influence of the gut microbiome in Parkinson’s Disease (#196)
7:45 PM
Jess Spithoven
Poster Session II & Trade Night